Patents by Inventor Christian J. Wiedermann

Christian J. Wiedermann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE IN BRAIN DEGENERATIVE DISEASES
    Publication number: 20140162964
    Abstract: Disclosed is a new use for sphingosine-1-phosphate (S1P) receptor agonists in the treatment of progressive dementia or brain degenerative diseases.
    Type: Application
    Filed: December 2, 2013
    Publication date: June 12, 2014
    Applicant: NOVARTIS AG
    Inventors: Volker Brinkmann, Nicole Kaneider, Christian J. Wiedermann
  • USE IN BRAIN DEGENERATIVE DISEASES
    Publication number: 20130281541
    Abstract: Disclosed is a new use for sphingosine-1-phosphate (S1P) receptor agonists in the treatment of progressive dementia or brain degenerative diseases.
    Type: Application
    Filed: June 18, 2013
    Publication date: October 24, 2013
    Inventors: Volker Brinkmann, Nicole Kaneider, Christian J. Wiedermann
  • Use of sphingosine-1 phosphate (S1P) receptor agonists for the treatment of brain degenerative diseases
    Patent number: 8519006
    Abstract: Disclosed is the use of sphingosine-1-phosphate (S1P) receptor agonists, preferably 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol, in the treatment of progressive dementia or brain degenerative diseases.
    Type: Grant
    Filed: September 17, 2010
    Date of Patent: August 27, 2013
    Assignee: Novartis AG
    Inventors: Volker Brinkmann, Nicole Kaneider, Christian J Wiedermann
  • Use of Sphingosine-1-phosphate (S1P) Receptor Agonists for the Treatment of Brain Degenerative Diseases
    Publication number: 20110124739
    Abstract: Disclosed is the use of sphingosine-1-phosphate (S1P) receptor agonists, preferably 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol, in the treatment of progressive dementia or brain degenerative diseases
    Type: Application
    Filed: September 17, 2010
    Publication date: May 26, 2011
    Inventors: Volker Brinkmann, Nicole Kaneider, Christian J. Wiedermann
  • Use of Sphingosine-1-Phosphate (S1P) Receptor Agonists For the Treatment of Brain Degenerative Diseases
    Publication number: 20080139662
    Abstract: Disclosed is the use of sphingosine-1-phosphate (S1P) receptor agonists, preferably 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol, in the treatment of progressive dementia or brain degenerative diseases.
    Type: Application
    Filed: December 17, 2004
    Publication date: June 12, 2008
    Inventors: Volker Brinkmann, Nicole Kaneider, Christian J. Wiedermann